XML 31 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 3 - Fair Value Measurements
12 Months Ended
Mar. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]  
Fair Value Measurements

3. Fair value measurements

 

Assets and liabilities measured at fair value on a recurring basis as of March 31, 2024 are as follows:

 

 

Total

 

 

Quoted prices in active markets (Level 1)

 

 

Significant other observable inputs (Level 2)

 

 

Significant unobservable inputs (Level 3)

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

   Guaranteed investment certificates and term deposits
   classified as cash equivalents

 

 

19,725

 

 

 

19,725

 

 

 

 

 

 

 

 

Total assets

 

 

19,725

 

 

 

19,725

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

   Derivative warrant liabilities

 

 

4,359

 

 

 

 

 

 

 

 

 

4,359

 

 

Total liabilities

 

 

4,359

 

 

 

 

 

 

 

 

 

4,359

 

 

 

Assets measured at fair value on a recurring basis as of March 31, 2023 are as follows:

 

 

Total

 

 

Quoted prices in active markets (Level 1)

 

 

Significant other observable inputs (Level 2)

 

 

Significant unobservable inputs (Level 3)

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

   Term deposits classified as cash equivalents

 

 

10,072

 

 

 

10,072

 

 

 

 

 

 

 

 

   Guaranteed investment certificate classified as a
   short-term investment

 

 

15

 

 

 

15

 

 

 

 

 

 

 

 

Total assets

 

 

10,087

 

 

 

10,087

 

 

 

 

 

 

 

 

 

There were no changes in valuation techniques or transfers between Levels 1, 2 or 3 during the years ended March 31, 2024 and 2023. The Company’s derivative warrant liabilities are measured at fair value on a recurring basis using unobservable inputs that are classified as Level 3 inputs. Refer to Note 10(b) for the valuation techniques and assumptions used in estimating the fair value of the derivative warrant liabilities.